Ines Pfeil

456 total citations
8 papers, 303 citations indexed

About

Ines Pfeil is a scholar working on Pathology and Forensic Medicine, Molecular Biology and Oncology. According to data from OpenAlex, Ines Pfeil has authored 8 papers receiving a total of 303 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Pathology and Forensic Medicine, 4 papers in Molecular Biology and 4 papers in Oncology. Recurrent topics in Ines Pfeil's work include Lymphoma Diagnosis and Treatment (5 papers), DNA Repair Mechanisms (2 papers) and PARP inhibition in cancer therapy (2 papers). Ines Pfeil is often cited by papers focused on Lymphoma Diagnosis and Treatment (5 papers), DNA Repair Mechanisms (2 papers) and PARP inhibition in cancer therapy (2 papers). Ines Pfeil collaborates with scholars based in Germany, Italy and Netherlands. Ines Pfeil's co-authors include Ralf Küppers, Enrico Tiacci, Wolfram Klapper, Claudia Döring, Carel J.M. van Noesel, Andreas Bräuninger, Martin‐Leo Hansmann, Susan Eckerle, Anja von Heydebreck and Brunangelo Falini and has published in prestigious journals such as Nucleic Acids Research, The Journal of Experimental Medicine and Blood.

In The Last Decade

Ines Pfeil

8 papers receiving 302 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Ines Pfeil Germany 6 176 144 107 101 52 8 303
Katrin Bertram Switzerland 9 125 0.7× 145 1.0× 134 1.3× 144 1.4× 51 1.0× 10 359
Kerstin Dietze Germany 6 147 0.8× 137 1.0× 112 1.0× 125 1.2× 96 1.8× 8 319
Hannelore Madle Germany 5 173 1.0× 142 1.0× 88 0.8× 159 1.6× 117 2.3× 6 347
Avery Polk United States 7 167 0.9× 139 1.0× 160 1.5× 75 0.7× 50 1.0× 14 313
Matias Autio Finland 8 180 1.0× 157 1.1× 91 0.9× 112 1.1× 32 0.6× 19 328
Bishan Ye United States 5 234 1.3× 165 1.1× 70 0.7× 71 0.7× 161 3.1× 7 324
Isabel Romero-Camarero Spain 7 175 1.0× 172 1.2× 88 0.8× 191 1.9× 73 1.4× 11 412
Stefano Rosati Netherlands 8 229 1.3× 174 1.2× 35 0.3× 80 0.8× 120 2.3× 12 333
Julie Agopian France 7 156 0.9× 109 0.8× 114 1.1× 73 0.7× 105 2.0× 13 302
James Watkins United Kingdom 7 176 1.0× 98 0.7× 95 0.9× 77 0.8× 110 2.1× 14 307

Countries citing papers authored by Ines Pfeil

Since Specialization
Citations

This map shows the geographic impact of Ines Pfeil's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ines Pfeil with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ines Pfeil more than expected).

Fields of papers citing papers by Ines Pfeil

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ines Pfeil. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ines Pfeil. The network helps show where Ines Pfeil may publish in the future.

Co-authorship network of co-authors of Ines Pfeil

This figure shows the co-authorship network connecting the top 25 collaborators of Ines Pfeil. A scholar is included among the top collaborators of Ines Pfeil based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ines Pfeil. Ines Pfeil is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

8 of 8 papers shown
1.
Mortusewicz, Oliver, Angelika Schmidt, Arthur Fischbach, et al.. (2019). Restriction of AID activity and somatic hypermutation by PARP-1. Nucleic Acids Research. 47(14). 7418–7429. 7 indexed citations
2.
Böttcher, Katrin, Angelika Schmidt, Elisabeth Kremmer, et al.. (2016). PARP activation promotes nuclear AID accumulation in lymphoma cells. Oncotarget. 7(11). 13197–13208. 6 indexed citations
3.
Pfeil, Ines, et al.. (2012). Abstract 2519: U3-1565, a fully human anti-HB-EGF monoclonal antibody, inhibits oncogenic signaling and tumor cell growth in vitro and in vivo. Cancer Research. 72(8_Supplement). 2519–2519. 2 indexed citations
4.
Scheller, Henrik Vibe, et al.. (2009). c-Myc overexpression promotes a germinal center-like program in Burkitt's lymphoma. Oncogene. 29(6). 888–897. 20 indexed citations
5.
Tiacci, Enrico, Verena Brune, Susan Eckerle, et al.. (2009). New Pathogenetic Insights Into Classical Hodgkin Lymphoma Revealed by Gene Expression Profiling of Microdissected Hodgkin/Reed-Sternberg Cells.. Blood. 114(22). 266–266. 1 indexed citations
6.
Brune, Verena, Enrico Tiacci, Ines Pfeil, et al.. (2008). Origin and pathogenesis of nodular lymphocyte–predominant Hodgkin lymphoma as revealed by global gene expression analysis. The Journal of Experimental Medicine. 205(10). 2251–2268. 237 indexed citations
7.
Brune, Verena, Enrico Tiacci, Ines Pfeil, et al.. (2008). Brune V, Tiacci E, Pfeil I, Döring C, Eckerle S, van Noesel CJ et al.. Origin and pathogenesis of nodular lymphocyte-predominant Hodgkin lymphoma as revealed by global gene expression analysis. J Exp Med 205: 2251-2268. 11 indexed citations
8.
Kluiver, Joost, Klaas Kok, Ines Pfeil, et al.. (2006). Global correlation of genome and transcriptome changes in classical Hodgkin lymphoma. Hematological Oncology. 25(1). 21–29. 19 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026